JPH0349555B2 - - Google Patents
Info
- Publication number
- JPH0349555B2 JPH0349555B2 JP9244182A JP9244182A JPH0349555B2 JP H0349555 B2 JPH0349555 B2 JP H0349555B2 JP 9244182 A JP9244182 A JP 9244182A JP 9244182 A JP9244182 A JP 9244182A JP H0349555 B2 JPH0349555 B2 JP H0349555B2
- Authority
- JP
- Japan
- Prior art keywords
- cystine
- cysteine
- atc
- ferm
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 34
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 24
- 229960003067 cystine Drugs 0.000 claims description 24
- 239000004158 L-cystine Substances 0.000 claims description 15
- 235000019393 L-cystine Nutrition 0.000 claims description 15
- 239000004201 L-cysteine Substances 0.000 claims description 13
- 235000013878 L-cysteine Nutrition 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 239000011593 sulfur Substances 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- VHPXSBIFWDAFMB-UHFFFAOYSA-N 2-amino-Delta(2)-thiazoline-4-carboxylic acid Chemical compound NC1=[NH+]C(C([O-])=O)CS1 VHPXSBIFWDAFMB-UHFFFAOYSA-N 0.000 claims description 2
- GOWFWTOTIYYJSE-UHFFFAOYSA-N 3-carbamimidoylsulfanyl-2-chloropropanoic acid Chemical compound NC(=N)SCC(Cl)C(O)=O GOWFWTOTIYYJSE-UHFFFAOYSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 9
- 235000018417 cysteine Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000589565 Flavobacterium Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000192041 Micrococcus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 2
- 241000590020 Achromobacter Species 0.000 description 2
- 241000588986 Alcaligenes Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241001600125 Delftia acidovorans Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000588915 Klebsiella aerogenes Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 241001135976 Mycoplana dimorpha Species 0.000 description 2
- 241000588701 Pectobacterium carotovorum Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000607715 Serratia marcescens Species 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 241001453369 Achromobacter denitrificans Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 241000125240 Dimorpha Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000721603 Mycoplana Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000011437 continuous method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- -1 hair Chemical compound 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002816 microbial assay Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
この発明は、L−含硫アミノ酸、詳しくはL−
システインおよびL−シスチンの製造法に関す
る。
従来、L−システインおよびL−シスチンは、
毛髪等のL−システインやL−シスチンの含量の
高い天然物を鉱酸で加水分解し、生じたアミノ酸
混液よりL−シスチンとして単離取得し、L−シ
ステインはこのようにして得られたL−シスチン
を還元して製造されていた。
これに対し、本出願人においては既に、2−ア
ミノ−チアゾリン−4−カルボン酸(以下、
ATCと記す。)を原料とし、微生物の作用を利用
してL−システイン又はL−シスチンを製造する
方法(特開昭51−136619号公報参照)を開発し
た。
この方法に於いては、ATCを含硫アミノ酸に
変換する能力を有する微生物が酵素源として使用
され、この酵素は誘導酵素であるため、酵素誘導
剤として原料のATCが必要とされている。しか
しながらATCは高価であり、原料の1部を酵素
誘導剤として使用することは経済的ではなく、こ
の方法を工業的に実施し、含硫アミノ酸を安価に
製造するためには、ATCに代る安価な酵素誘導
剤が望まれていた。そこで、本発明者等は安価な
酵素誘導剤を開発することを目的として種々研究
を重ねた結果、ATCに代る誘導剤として、DL−
ATCの化学合成中間体である安価なS−(β−カ
ルボキシ−β−クロルエチル)−イソチオウレア
(以下、SCCIと記す。)が使用できることを発見
し本発明を完成するに至つた。即ち、本発明は
ATCを含硫アミノ酸に変換する能力を有する微
生物をSCCIを含む培地で培養し、培養した微生
物をATCに作用させて含硫アミノ酸に変換せし
めることを特徴とする含硫アミノ酸の製造方法に
係るものである。
本発明において使用する微生物は、自然界に存
在する野生株、公的な微生物保存機関に保存され
ている菌株或いはそれらより人工的に変異誘導し
た微生物群より、ATCからのシスチン又は(及
び)システイン生産能の有無を調べることによつ
て分離採取されるものであり、たとえば、アクロ
モバクター、アルカリゲネス、バチルス、ブレビ
バクテリウム、エンテロバクター、エルビニア、
エツシエリヒア、フラボバクテリウム、ミクロコ
ツカス、ミコプラナ、シユードモナス、サルシナ
あるいはセラチアの各属に属する微生物である。
より具体的に例示するならば次の如き菌株があげ
られる:
サルチナ・ルテアAJ−1217(Sarcina lutea)
ATCC272、アクロモバクター・デルマルバアAJ
−1983(Achremebaeter delmarvae)FERM−
P3483、アルカリゲネス・デニトロフインカスAJ
−2553(Alcaligenes denitrificans)
ATCC15173、パチルス・ブレビスAJ−1282
(Bacillus brevis)ATCC8185、ブレビバクテリ
ウム・フラバムAJ−1516(Brevibaeterium
flavum)ATCC13826、エンテロバクター・アエ
ロゲネスAJ−2643(Enterobacter aerogenes
IAM1019)FERM−P2764、エルビニア・カロト
ボラAJ−2753(Erwinia carotovora CCM873)
FERM−P2766、シユードモナス・チアゾリノフ
イラムAJ−3854(Pseudomonas
thiazolinophilum)FERM−P2810、シユードモ
ナス・デスモリチカAJ2368(P.desmolyitca)
FERM−P2816、エツシエリヒア・コリAJ−
2592(Escherichia coli IAM1132)FERM−
P2763、ミクロコツカス・ソドンシスAJ−1753
(Micrococcus sodonensis)ATCC11800、ミコ
プラナ・ジモルフアAJ−2809(Mycoplana
dimorpha)ATCC4249、セラチア・マツセツセ
ンスAJ−2698(Serratia marcescens IAM1206)
FERM−P2765、フラボバクテリウム・アシドフ
イクムAJ−2494(Flavobacterium acidoficum)
ATCC8366、プソイドモナス・オバリスAJ−
2236(Pseudomenas ovalis IAM1454)FERM−
P2762
原料であるATCは、合成法にて供給されるも
ので、一般にラセミ体である。しかし本発明の方
法によれば、D−体、L−体ともにL−体のシス
チンまたはシステインに変換される。
前述の如き微生物を培養するための培地は
SCCIを0.01〜3%含有する栄養培地が使用され
る。SCCIはATCの化学合成中間体であり、ATC
に比べて安価である。栄養培地としては炭素源、
窒素源、無機イオン類、更に要すれば有機微量栄
養素を適宜含有する培地である。たとえば、炭素
源としてグルコース、シユクロース、キシロー
ス、糖蜜等の糖類、酢酸等の有機酸、エタノー
ル、グリセロール、メタノール等のアルコール類
などの、窒素源として硫酸アンモニウム、塩化ア
ンモニウムなど、有機栄養源として酵母エキス、
ペプトン、肉エキス、コーン・ステイープリカー
など無機イオンとして、マグネシウム、鉄、マン
ガン、カリウム、ナトリウム、リン酸などのイオ
ンが適宜用いられる。
培養は常法によればよく、たとえば培地のPHは
6〜9とし、接種後、20〜40℃で1〜3日好気的
に培養する。
このようにして培養した微生物を基質のATC
に作用せしめてATCを含硫アミノ酸を生成せし
める。
上記培養した微生物とは培養して得られる培養
液、分離菌体、洗滌生菌体、凍結乾燥菌体、アセ
トン乾燥菌体、物理的、化学的もしくは生化学的
に破壊された菌体、抽出液、粗精製物、精製物、
精製蛋白標晶、または菌体もしくは精製処理物の
固定化物などをいい、ATCに作用させる際の基
質濃度は、バツチ式、連続式によつても異なる
が、バツチ式では一般に水性媒質中0.1〜30%、
好ましくは0.5〜10%程度で連続式では、これよ
りやや濃度を低下させた方が好ましい。
反応は、普通、水性媒質中で15〜60℃、好まし
くは30℃〜50℃附近で、PH=6〜10、好ましくは
7.0〜9.5附近で行なわれる。反応時間は、静置、
撹拌、流下等の手段あるいは酵素標品の形態、力
価によつて異なつてくるので一様ではないが、バ
ツチ法では通常10分〜72時間程度である。
反応が進行すると、反応液中にL−システイン
とL−シスチンが共存するのであるが、通常L−
システインは空気中の酸素により酸化されてL−
シスチンに変化し易く、時間がたつにつれてL−
シスチンの量が増大する。しかしながら、反応条
件等の変更によつてL−システインとL−シスチ
ンの濃度比を変えることも可能である。
一般には、通気酸化により大部分をL−シスチ
ンとし、その難溶性を利用して晶析する方法によ
りL−シスチンを得ることができた。また、L−
システインにする場合は電気還元による通常の方
法で処理して、L−システインとして採取するこ
とができる。なお、反応液にヒドロキシルアミン
やセミカルバジドを添加することによつてL−シ
ステイン及び/またはL−シスチンの収率を向上
することができる。
L−シスチンとL−システインの定量は、液体
クロマトグラフイーと微生物定量法によつた。後
者は乳酸菌ロイコノストツク・チトロボラム
ATCC8081を用いる方法であるが、本菌はL−シ
スチンとL−システインの双方によつて何等の生
育を与えられるので両アミン酸の和を定量するこ
とになり、通常L−シスチンとして表示される。
なお、本菌はD体のシスチン、システインでは生
育できない。
実施例 1
第1表に示す組成の培地を調整し、500ml容フ
ラスコに50ml宛分注し120℃で10分間加熱・減菌
した。
This invention relates to L-sulfur-containing amino acids, specifically L-
The present invention relates to a method for producing cysteine and L-cystine. Conventionally, L-cysteine and L-cystine are
L-cysteine, such as hair, and natural products with a high content of L-cysteine are hydrolyzed with mineral acids, and L-cysteine is isolated from the resulting amino acid mixture. -Produced by reducing cystine. In contrast, the present applicant has already developed 2-amino-thiazoline-4-carboxylic acid (hereinafter referred to as
It is written as ATC. ) was used as a raw material, and a method for producing L-cysteine or L-cystine using the action of microorganisms was developed (see Japanese Patent Application Laid-Open No. 136619/1983). In this method, a microorganism having the ability to convert ATC into a sulfur-containing amino acid is used as an enzyme source, and since this enzyme is an inducible enzyme, the raw material ATC is required as an enzyme inducer. However, ATC is expensive, and it is not economical to use part of the raw material as an enzyme inducer. An inexpensive enzyme inducer has been desired. Therefore, as a result of various research aimed at developing an inexpensive enzyme inducer, the present inventors found that DL-
The present invention was completed by discovering that an inexpensive S-(β-carboxy-β-chloroethyl)-isothiourea (hereinafter referred to as SCCI), which is an intermediate in the chemical synthesis of ATC, can be used. That is, the present invention
A method for producing a sulfur-containing amino acid, which comprises culturing a microorganism capable of converting ATC into a sulfur-containing amino acid in a medium containing SCCI, and allowing the cultured microorganism to act on ATC to convert it into a sulfur-containing amino acid. It is. The microorganisms used in the present invention are wild strains existing in nature, strains stored in public microbial repositories, or microorganisms artificially mutagenized from them, and cystine or (and) cysteine production from ATC is used. For example, Achromobacter, Alcaligenes, Bacillus, Brevibacterium, Enterobacter, Erwinia,
These microorganisms belong to the genera Ethscherichia, Flavobacterium, Micrococcus, Mycoplana, Pseudomonas, Sarcina, or Serratia.
More specific examples include the following strains: Sarcina lutea AJ-1217 (Sarcina lutea)
ATCC272, Achromobacter delmalvaa AJ
−1983 (Achremebaeter delmarvae) FERM−
P3483, Alcaligenes denitrophincus AJ
−2553 (Alcaligenes denitrificans)
ATCC15173, Pacillus brevis AJ-1282
(Bacillus brevis) ATCC8185, Brevibacterium flavum AJ-1516 (Brevibaeterium
flavum) ATCC13826, Enterobacter aerogenes AJ-2643 (Enterobacter aerogenes
IAM1019) FERM-P2764, Erwinia carotovora AJ-2753 (Erwinia carotovora CCM873)
FERM-P2766, Pseudomonas thiazolinophyllum AJ-3854 (Pseudomonas
thiazolinophilum) FERM-P2810, Pseudomonas desmolytica AJ2368 (P.desmolyitca)
FERM−P2816, Etschierhia coli AJ−
2592 (Escherichia coli IAM1132) FERM−
P2763, Micrococcus sodonsis AJ−1753
(Micrococcus sodonensis) ATCC11800, Mycoplana dimorpha AJ-2809 (Mycoplana dimorpha AJ-2809)
dimorpha) ATCC4249, Serratia marcescens AJ-2698 (Serratia marcescens IAM1206)
FERM-P2765, Flavobacterium acidoficum AJ-2494 (Flavobacterium acidoficum)
ATCC8366, Pseudomonas obalis AJ−
2236 (Pseudomenas ovalis IAM1454) FERM−
P2762 The raw material ATC is supplied by a synthetic method and is generally racemic. However, according to the method of the present invention, both the D-form and the L-form are converted to L-form cystine or cysteine. The medium for culturing the microorganisms mentioned above is
A nutrient medium containing 0.01-3% SCCI is used. SCCI is a chemical synthesis intermediate of ATC,
It is cheaper than. As a nutrient medium, carbon source,
The medium contains a nitrogen source, inorganic ions, and, if necessary, organic micronutrients as appropriate. For example, carbon sources include sugars such as glucose, sucrose, xylose, and molasses; organic acids such as acetic acid; and alcohols such as ethanol, glycerol, and methanol; nitrogen sources include ammonium sulfate and ammonium chloride; organic nutritional sources include yeast extract;
Ions such as magnesium, iron, manganese, potassium, sodium, and phosphoric acid are appropriately used as inorganic ions such as peptone, meat extract, and corn staple liquor. Cultivation may be carried out by a conventional method, for example, the pH of the medium is set to 6 to 9, and after inoculation, the culture is carried out aerobically at 20 to 40°C for 1 to 3 days. The microorganisms cultured in this way are used as a substrate for ATC.
It acts on ATC to produce sulfur-containing amino acids. The above-mentioned cultured microorganisms are culture fluid obtained by culturing, isolated bacterial cells, washed living bacterial cells, freeze-dried bacterial cells, acetone-dried bacterial cells, physically, chemically or biochemically destroyed bacterial cells, and extracted bacterial cells. liquid, crudely purified product, purified product,
It refers to a purified protein standard, or an immobilized product of bacterial cells or a purified product.The substrate concentration when acting on ATC differs depending on whether it is a batch method or a continuous method, but in a batch method, it is generally 0.1 to 0.1 in an aqueous medium. 30%,
Preferably, it is about 0.5 to 10%, and in a continuous system, it is preferable to lower the concentration slightly. The reaction is usually carried out in an aqueous medium at 15-60°C, preferably around 30-50°C, and at a pH of 6-10, preferably
It is held around 7.0 to 9.5. Reaction time: standing still;
The batch method usually takes about 10 minutes to 72 hours, although it is not uniform because it depends on the means of stirring, flowing down, etc., and the form and potency of the enzyme preparation. As the reaction progresses, L-cysteine and L-cystine coexist in the reaction solution, but usually L-cysteine coexists with L-cysteine.
Cysteine is oxidized by oxygen in the air and L-
It easily changes to cystine, and over time it changes to L-
The amount of cystine increases. However, it is also possible to change the concentration ratio of L-cysteine and L-cystine by changing reaction conditions and the like. In general, L-cystine could be obtained by converting most of it into L-cystine by aeration oxidation and crystallizing it by taking advantage of its poor solubility. Also, L-
When producing cysteine, it can be collected as L-cysteine by a conventional method of electroreduction. Note that the yield of L-cysteine and/or L-cystine can be improved by adding hydroxylamine or semicarbazide to the reaction solution. Quantification of L-cystine and L-cysteine was carried out by liquid chromatography and microbial assay. The latter is the lactic acid bacterium Leuconostocci titroborum.
This method uses ATCC8081, but since this bacterium depends on both L-cystine and L-cysteine, the sum of both amino acids is quantified, and it is usually expressed as L-cystine. .
Note that this bacterium cannot grow on D-form cystine or cysteine. Example 1 A culture medium having the composition shown in Table 1 was prepared, and 50 ml was dispensed into a 500 ml flask and sterilized by heating at 120° C. for 10 minutes.
【表】
この培地にシユードモナス・デスモリチカ
FERM−P2816を接種し、30℃にて24時間振盪培
養を行つた。
各培養液5.0mlに1.0g/dlのDL−ATC及び1.0
g/dlのKH2PO4を含む5.0ml(PH8.0)を添加し、
30℃で5時間反応せしめた。
反応液中に生成したシステイン、シスチンの量
を高速液体クロマトグラフイーに定量した。その
結果を第2表に示す。[Table] In this medium, Pseudomonas desmolytica
FERM-P2816 was inoculated and cultured with shaking at 30°C for 24 hours. 1.0 g/dl DL-ATC and 1.0 g/dl in each 5.0 ml culture solution
Add 5.0 ml (PH 8.0) containing g/dl KH 2 PO 4 ,
The reaction was carried out at 30°C for 5 hours. The amounts of cysteine and cystine produced in the reaction solution were determined using high performance liquid chromatography. The results are shown in Table 2.
【表】
上記SCCI0.1g/dl添加して得られた培養液50
mlを遠心分離して菌体を集め、水で洗浄した後、
この菌体をDL−ATC・3H2O 3.0g及びKH2PO4
1.0gを含むPH8.0の水溶液100mlに添加し、30℃
で15時間ゆるやかに撹拌しながら反応した。
反応終了後、反応液を激しく撹拌してシステイ
ンをシスチンに変換して結晶を析出せしめた。次
いで濃塩酸を添加して結晶を溶解後、遠心分離し
て不溶性物質を除去した。得られた上清に苛性ソ
ーダ溶液を加え、中和して結晶を析出せしめた。
再結を再度行つて白色の結晶1.7gを得た。
この結晶はNMRスペクトル、X線回析、およ
び液体クロマトグラフイーに於てオーセンテイク
なL−シスチンと完全に一致し、L−シスチンと
同定された。
実施例 2
第1表に示す組成の培地(SCCI:0.1g/dl)
を使用して第3表に示す試験菌を実施例1と同様
の方法で培養した。培養液5.0mlを、5.0mlのDL−
ATC水溶液(DLATC2.0g/dl、KH2PO4 1.0
g/dl、PH8.0)と混合し、30℃にて5時間反応
せしめた。反応液中のシステイン及びシスチンを
高速液体クロマトグラフイーにて定量した。その
結果を第3表に示す。[Table] Culture solution 50 obtained by adding SCCI 0.1g/dl above
After centrifuging ml to collect bacterial cells and washing with water,
This bacterial cell was added to DL-ATC・3H 2 O 3.0g and KH 2 PO 4
Add to 100ml of PH8.0 aqueous solution containing 1.0g and heat at 30℃.
The mixture was reacted for 15 hours with gentle stirring. After the reaction was completed, the reaction solution was vigorously stirred to convert cysteine to cystine and precipitate crystals. Concentrated hydrochloric acid was then added to dissolve the crystals, followed by centrifugation to remove insoluble substances. A caustic soda solution was added to the obtained supernatant to neutralize it and precipitate crystals.
Recrystallization was performed again to obtain 1.7 g of white crystals. This crystal completely matched authentic L-cystine in its NMR spectrum, X-ray diffraction, and liquid chromatography, and was identified as L-cystine. Example 2 Medium with the composition shown in Table 1 (SCCI: 0.1g/dl)
The test bacteria shown in Table 3 were cultured in the same manner as in Example 1. Transfer 5.0ml of culture solution to 5.0ml DL−
ATC aqueous solution (DLATC2.0g/dl, KH 2 PO 4 1.0
g/dl, pH 8.0) and reacted at 30°C for 5 hours. Cysteine and cystine in the reaction solution were quantified using high performance liquid chromatography. The results are shown in Table 3.
Claims (1)
L−システイン又はL−シスチンに変換する能力
を有する微生物をS−(β−カルボキシ−β−ク
ロルエチル)−イソチオウレアを含む培地で培養
し、培養した微生物を2−アミノ−チアゾリン−
4−カルボン酸に作用させてL−システイン又は
L−シスチンを生成せしめることを特徴とするL
−含硫アミノ酸の製造法。1 A microorganism having the ability to convert 2-amino-thiazoline-4-carboxylic acid to L-cysteine or L-cystine was cultured in a medium containing S-(β-carboxy-β-chloroethyl)-isothiourea. Microorganisms are treated with 2-amino-thiazoline-
L-cysteine or L-cystine is produced by acting on 4-carboxylic acid.
- A method for producing a sulfur-containing amino acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9244182A JPS58209988A (en) | 1982-05-31 | 1982-05-31 | Preparation of sulfur-containing l-amino acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9244182A JPS58209988A (en) | 1982-05-31 | 1982-05-31 | Preparation of sulfur-containing l-amino acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58209988A JPS58209988A (en) | 1983-12-07 |
JPH0349555B2 true JPH0349555B2 (en) | 1991-07-29 |
Family
ID=14054499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9244182A Granted JPS58209988A (en) | 1982-05-31 | 1982-05-31 | Preparation of sulfur-containing l-amino acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58209988A (en) |
-
1982
- 1982-05-31 JP JP9244182A patent/JPS58209988A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS58209988A (en) | 1983-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1512488A3 (en) | Method of producing amide | |
JPS5937951B2 (en) | Biological production of amides | |
JP4197754B2 (en) | Method for producing lactic acid or succinic acid | |
JPH0349555B2 (en) | ||
JPS58201992A (en) | Preparation of beta-substituted propionic acid or amide thereof by microorganism | |
JPH0346115B2 (en) | ||
EP0187525B1 (en) | Process for producing l-serine | |
JP4198147B2 (en) | Method for producing organic acid | |
JPH1042886A (en) | Method for producing β-alanine by microorganism | |
JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
JPS608119B2 (en) | Method for producing L-sulfur-containing amino acids | |
JPH02207793A (en) | Production of d-beta-hydroxyamino acid | |
JPS6057833B2 (en) | Method for producing L-tryptophan | |
JP2899071B2 (en) | Method for producing L-α-alanine | |
JPS606625B2 (en) | Method for producing microbial cells | |
JPH0574353B2 (en) | ||
JPH05176794A (en) | Production of optically active 2-phenylpropionic acid and 2-phenylpropionamide | |
JPH0789948B2 (en) | 2 ▲ '▼ -Method for producing deoxycytidine | |
JPH03180188A (en) | Production of cysteine | |
JPH01228489A (en) | Production of d-n-carbamyl-alpha-amino acid | |
JPH0525476B2 (en) | ||
JPS5928489A (en) | Preparation of 2,2-dimethylthiazolidine-4-carboxylic acid | |
JPH0329395B2 (en) | ||
JPS6128398A (en) | Preparation of l-valine | |
JPH01112992A (en) | Production of l-isoleucine |